cGAS-mediated glial responses to DNA damage: A pilot study

cGAS 介导的神经胶质细胞对 DNA 损伤的反应:一项初步研究

基本信息

项目摘要

Abstract Genomic instability is a major driving force for cancer and age-related diseases. While DNA damage responses were long thought to regulate genome integrity and cell fates, evidence is accumulating that genomic instability also triggers inflammatory responses. Recent studies have provided insight into the mechanisms underlying such responses with the demonstration that the cytosolic DNA sensor, cyclic GMP-AMP synthase (cGAS), can play a key role in linking DNA damage to innate immunity. Interestingly, our research team has recently described the ability of human microglia and astrocytes to respond to foreign cytosolic double-stranded DNA and we demonstrated that human glia show robust levels of cGAS protein expression at rest and following activation. Furthermore, we showed these cell types constitutively express the critical downstream cGAS adaptor protein, stimulator of interferon genes (STING). In this R03 pilot study, we will begin to test the hypothesis that the cGAS-STING pathway detects cytoplasmic DNA in microglia and/or astrocytes after genotoxic stress and initiates glial auto- inflammatory responses. This project stems from a new collaboration between two experienced investigators with complementary expertise in the study of DNA damage repair mechanisms and glial innate immune sensor molecules. In these preliminary studies, we will determine whether genomic DNA damage elicits micronuclei formation and an elevation in the level of the cGAS product cGAMP in cultured glia, and we will correlate such responses with the production of auto-inflammatory mediators or potentially anti-tumor factors such as type I interferon. Furthermore, we will directly assess the relative importance of the cGAS-STING pathway in glial responses to DNA damage following pharmacological inhibition and/or CRISPR/cas9 genome editing. The proposed pilot R03 studies are an important first step in this new research direction and will provide a solid rationale for a more comprehensive investigation into the role of the cGAS-STING pathway in CNS cellular senescence and cancer for which future R01 mechanism support will be sought.
摘要 基因组不稳定性是癌症和与年龄有关的疾病的主要驱动力。而 DNA损伤反应长期以来被认为是调节基因组完整性和细胞命运的, 越来越多的证据表明,基因组的不稳定性也会引发炎症反应。 最近的研究提供了对这种反应背后的机制的深入了解 证明了细胞质DNA传感器,环GMP-AMP合酶 cGAS(cGAS)可以在将DNA损伤与先天免疫联系起来方面发挥关键作用。有趣的是,我们 一个研究小组最近描述了人类小胶质细胞和星形胶质细胞的能力, 对外源胞质双链DNA的反应,我们证明了人类神经胶质细胞 在静止和活化后显示出强水平的cGAS蛋白表达。 此外,我们发现这些细胞类型组成性表达关键的下游蛋白。 cGAS衔接蛋白,干扰素基因刺激因子(STING)。在R 03初步研究中, 我们将开始检验cGAS-STING途径检测细胞质内 基因毒性应激后小胶质细胞和/或星形胶质细胞中的DNA,并启动胶质细胞自 炎症反应。这个项目源于两个人之间的新合作 在DNA损伤研究方面具有互补专业知识的经验丰富的研究人员 修复机制和神经胶质先天免疫传感器分子。在这些初步 研究中,我们将确定基因组DNA损伤是否诱发微核形成 以及培养的神经胶质细胞中cGAS产物cGAMP水平的升高,我们将 将这些反应与自身炎症介质的产生相关联,或 潜在的抗肿瘤因子如I型干扰素。此外,我们将直接 评估cGAS-STING通路在神经胶质细胞对DNA反应中的相对重要性 药理学抑制和/或CRISPR/cas9基因组编辑后的损伤。的 拟议的R 03试点研究是这一新研究方向的重要第一步, 将提供一个坚实的理由,更全面的调查的作用, cGAS-STING通路在CNS细胞衰老和癌症中的作用,未来R 01 将寻求机制支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christine A. Richardson其他文献

Christine A. Richardson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christine A. Richardson', 18)}}的其他基金

cGAS-mediated glial responses to DNA damage: A pilot study
cGAS 介导的神经胶质细胞对 DNA 损伤的反应:一项初步研究
  • 批准号:
    10019417
  • 财政年份:
    2019
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of translocations in hematopoietic cells
造血细胞易位的病因学
  • 批准号:
    7116610
  • 财政年份:
    2005
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of translocations in hematopoietic cells
造血细胞易位的病因学
  • 批准号:
    7054099
  • 财政年份:
    2003
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of translocations in hematopoietic cells
造血细胞易位的病因学
  • 批准号:
    6749584
  • 财政年份:
    2003
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of translocations in hematopoietic cells
造血细胞易位的病因学
  • 批准号:
    6891415
  • 财政年份:
    2003
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of translocations in hematopoietic cells
造血细胞易位的病因学
  • 批准号:
    7622901
  • 财政年份:
    2003
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of Translocations in Hematopoietic Cells
造血细胞易位的病因学
  • 批准号:
    8193254
  • 财政年份:
    2003
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of Translocations in Hematopoietic Cells
造血细胞易位的病因学
  • 批准号:
    8290504
  • 财政年份:
    2003
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of translocations in hematopoietic cells
造血细胞易位的病因学
  • 批准号:
    6597394
  • 财政年份:
    2003
  • 资助金额:
    $ 7.14万
  • 项目类别:
Etiology of Translocations in Hematopoietic Cells
造血细胞易位的病因学
  • 批准号:
    7876939
  • 财政年份:
    2003
  • 资助金额:
    $ 7.14万
  • 项目类别:

相似海外基金

Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
通过间质局部消融免疫疗法增强全身抗肿瘤反应,与转移性胰腺肿瘤的免疫检查点疗法协同作用
  • 批准号:
    10580071
  • 财政年份:
    2022
  • 资助金额:
    $ 7.14万
  • 项目类别:
Development of new cancer treatment utilizing the enhancement of antitumor response caused by allo reaction
利用同种异体反应增强抗肿瘤反应开发新的癌症治疗方法
  • 批准号:
    20K17649
  • 财政年份:
    2020
  • 资助金额:
    $ 7.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of CD4 T cells and APCs in the induction and maintenance of an effective antitumor response
CD4 T 细胞和 APC 在诱导和维持有效抗肿瘤反应中的作用
  • 批准号:
    nhmrc : 143674
  • 财政年份:
    2001
  • 资助金额:
    $ 7.14万
  • 项目类别:
    NHMRC Project Grants
ANTICD20 MEDIATED SIGNALING AND ANTITUMOR RESPONSE
ANTICD20 介导的信号传导和抗肿瘤反应
  • 批准号:
    2377164
  • 财政年份:
    1997
  • 资助金额:
    $ 7.14万
  • 项目类别:
ANTICD20 MEDIATED SIGNALING AND ANTITUMOR RESPONSE
ANTICD20 介导的信号传导和抗肿瘤反应
  • 批准号:
    2712876
  • 财政年份:
    1997
  • 资助金额:
    $ 7.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了